Arthur A Levin

Director

Arthur A Levin (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in RNA. The largest single filing was $127K of RNA (1,758 sh × $72.45, as filed), executed Jan 21.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$127K

shares × price, as filed

Last traded

Jan 21

Filed Jan 23

Open performance→

Volume by month

Buys $0 Sells $5.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 1 filing

Sector per market data · by filing · past 12 months

Most traded names

RNA RNA RNA · 0 buys · 4 sells 4 filings

Recent filings

RNASALE Avidity Biosciences, Inc. View filing → $127K
1,758 sh × $72.45
Exec Jan 21
Filed Jan 23 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $5.1M
107,500 sh × $47.62
Exec Aug 6 2025
Filed Aug 8 2025 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $140K
3,323 sh × $42.12
Exec Nov 19 2024
Filed Nov 20 2024 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $233K
5,000 sh × $46.63
Exec Oct 21 2024
Filed Oct 23 2024 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $229K
5,000 sh × $45.73
Exec Sep 19 2024
Filed Sep 20 2024 · 5:30 PM ET